metformin has been researched along with Pancreatitis, Chronic in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin inhibited pancreatic cancer initiation, suppressed chronic pancreatitis-induced tumorigenesis, and showed promising therapeutic effect in PDAC." | 3.85 | Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. ( Cao, J; Chen, K; Cheng, L; Duan, W; Gao, L; Jiang, Z; Lei, M; Li, J; Ma, Q; Qian, W; Sun, L; Yan, B; Zhou, C, 2017) |
| "We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an established primary tumor in the pancreas and if administration of metformin has an impact on tumor growth." | 3.81 | Impact of diabetes type II and chronic inflammation on pancreatic cancer. ( Albert, AC; Amme, J; Bürtin, F; Partecke, LI; Radecke, T; Vollmar, B; Zechner, D, 2015) |
| "Hepatic insulin resistance is characteristic of T3cDM and is caused by deficiencies of both insulin and pancreatic polypeptide." | 2.47 | Pancreatogenic diabetes: special considerations for management. ( Andersen, DK; Cui, Y, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dugic, A | 3 |
| Hagström, H | 3 |
| Dahlman, I | 3 |
| Rutkowski, W | 3 |
| Daou, D | 3 |
| Kulinski, P | 3 |
| Löhr, JM | 3 |
| Vujasinovic, M | 3 |
| Chen, K | 1 |
| Qian, W | 1 |
| Jiang, Z | 1 |
| Cheng, L | 1 |
| Li, J | 1 |
| Sun, L | 1 |
| Zhou, C | 1 |
| Gao, L | 1 |
| Lei, M | 1 |
| Yan, B | 1 |
| Cao, J | 1 |
| Duan, W | 1 |
| Ma, Q | 1 |
| Zechner, D | 1 |
| Radecke, T | 1 |
| Amme, J | 1 |
| Bürtin, F | 1 |
| Albert, AC | 1 |
| Partecke, LI | 1 |
| Vollmar, B | 1 |
| Cui, Y | 1 |
| Andersen, DK | 1 |
| Ringel, J | 1 |
| Lerch, MM | 1 |
| Mayerle, J | 1 |
2 reviews available for metformin and Pancreatitis, Chronic
| Article | Year |
|---|---|
Pancreatogenic diabetes: special considerations for management.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV In | 2011 |
[Pancreatic diseases: update 2011].
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Diabetes Mellitus; Diagnosis, D | 2011 |
3 other studies available for metformin and Pancreatitis, Chronic
| Article | Year |
|---|---|
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.
Topics: Acute Disease; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulins; Male; Metformin; | 2023 |
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.
Topics: Acute Disease; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulins; Male; Metformin; | 2023 |
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.
Topics: Acute Disease; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulins; Male; Metformin; | 2023 |
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.
Topics: Acute Disease; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulins; Male; Metformin; | 2023 |
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Topics: Animals; Carcinogenesis; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Disease Models, Animal; Di | 2017 |
Impact of diabetes type II and chronic inflammation on pancreatic cancer.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Cell Death; Cell Line, Tumor; Cell | 2015 |